Diabetic nephropathy (DN) is a major cause of end-stage renal disease, with no therapeutic interventions available to control its progression. Ferroptosis, an iron-dependent regulated cell death characterized by lipid peroxidation, plays a pivotal role in the pathogenesis of DN. Human umbilical cord mesenchymal stem cells (hUCMSCs) are an effective treatment modality for DN; however, the underlying mechanism of action remains unclear. The aim of the present study was to investigate whether hUCMSCs alleviate DN via inhibiting ferroptosis and its molecular mechanisms in type 2 diabetic mice and high-glucose and palmitate-stimulated human renal tubular epithelial cell (HK-11) models.
Results:
Our findings revealed that hUCMSCs improved the renal structure and function and tubular injuries. HUCMSC treatment can inhibit ferroptosis by decreasing iron content, reducing reactive oxygen species, malondialdehyde and 4-hydroxynonenal generation, decreasing the expression of positive ferroptosis mediator transferrin receptor 1 and long-chain acyl-CoA synthetase 4, and enhancing the expression of negative ferroptosis mediators (i.e., ferritin heavy chain, glutathione peroxidase 4, and system Xc-cystine/glutamate reverse transporter). Mechanistically, hUCMSC treatment inhibited c-Jun N-terminal kinase (JNK) and Kelch-like ECH-associated protein 1 (KEAP1) activation while increasing the expression of nuclear factor erythroid 2-related factor 2 (NRF2). Furthermore, pretreatment of HK-11 cells with NRF2 siRNA, the JNK inhibitor SP600125, or the JNK agonist anisomycin demonstrated the regulation of the JNK/KEAP1/NRF2 signaling pathway by hUCMSCs.
Innovation and Conclusion:
HUCMSCs inhibit ferroptosis in DN via the JNK/KEAP1/NRF2 signaling pathway, providing a new perspective and scientific evidence for treating DN. Antioxid. Redox Signal. 42, 807–826.
Get full access to this article
View all access options for this article.
References
1.
Abdel AzizMT, WassefMA, AhmedHH, et al.The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy. Diabetol Metab Syndr, 2014; 6(1):34; doi: 10.1186/1758-5996-6-34
2.
AyalaA, MuñozMF, ArgüellesS. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev, 2014; 2014:360438; doi: 10.1155/2014/360438
3.
BaiY, WangJ, HeZ, et al.Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor β (TGF-β)/SMAD pathway and pro-inflammatory cytokines. Med Sci Monit, 2019; 25:3069–3076; doi: 10.1265/9/msm.914860
4.
BairdL, YamamotoM. The molecular mechanisms regulating the KEAP1-NRF2 Pathway. Mol Cell Biol, 2020; 40(13):e00099-20; doi: 10.1128/mcb.00099-20
5.
ChenF, KangR, LiuJ, et al.The ACSL4 network regulates cell death and autophagy in diseases. Biology (Basel), 2023; 12(6):864; doi: 10.3390/biology12060864
6.
ChenF, KangR, TangD, et al.Ferroptosis: Principles and significance in health and disease. J Hematol Oncol, 2024; 17(1):41; doi: 10.1186/s13045-024-01564-3
7.
ChengH, ShiY, LiX, et al.Human umbilical cord mesenchymal stem cells protect against ferroptosis in acute liver failure through the IGF1-hepcidin-FPN1 axis and inhibiting iron loading. Acta Biochim Biophys Sin (Shanghai), 2024; 56(2):280–290; doi: 10.3724/abbs.2023275
8.
ChengHT, XuX, LimPS, et al.Worldwide epidemiology of diabetes-related end-stage renal disease, 2000–2015. Diabetes Care, 2021; 44(1):89–97; doi: 10.2337/dc20-1913
9.
ConradM, Friedmann AngeliJP. Glutathione peroxidase 4 (Gpx4) and ferroptosis: What’s so special about it? Mol Cell Oncol, 2015; 2(3):e995047; doi: 10.4161/23723556.2014.995047
10.
CoughlanMT, NguyenTV, PenfoldSA, et al.Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes. Clin Sci (Lond), 2016; 130(9):711–720; doi: 10.1042/cs20150838
11.
DixonSJ, LembergKM, LamprechtMR, et al.Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 2012; 149(5):1060–1072; doi: 10.1016/j.cell.2012.03.042
12.
DominiciM, Le BlancK, MuellerI, et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 2006; 8(4):315–317; doi: 10.1080/14653240600855905
13.
DoornJ, MollG, Le BlancK, et al.Therapeutic applications of mesenchymal stromal cells: Paracrine effects and potential improvements. Tissue Eng Part B Rev, 2012; 18(2):101–115; doi: 10.1089/ten.TEB.2011.0488
14.
FengH, LiuQ, DengZ, et al.Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis. Stem Cell Res Ther, 2022; 13(1):450; doi: 10.1186/s13287-022-03147-w
15.
FengX, WangS, SunZ, et al.Ferroptosis enhanced diabetic renal tubular injury via HIF-1α/HO-1 pathway in db/db mice. Front Endocrinol (Lausanne), 2021; 12:626390; doi: 10.3389/fendo.2021.626390
16.
GilbertRE. Proximal tubulopathy: Prime mover and key therapeutic target in diabetic kidney disease. Diabetes, 2017; 66(4):791–800; doi: 10.2337/db16-0796
17.
HaoY, HaoS, Andersen-NissenE, et al.Integrated analysis of multimodal single-cell data. Cell, 2021; 184(13):3573–3587.e29; doi: 10.1016/j.cell.2021.04.048
18.
HasegawaK, WakinoS, SimicP, et al.Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med, 2013; 19(11):1496–1504; doi: 10.1038/nm.3363
19.
KasaiS, MimuraJ, OzakiT, et al.Emerging regulatory role of Nrf2 in iron, heme, and hemoglobin metabolism in physiology and disease. Front Vet Sci, 2018; 5:242; doi: 10.3389/fvets.2018.00242
20.
KimS, KangSW, JooJ, et al.Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis, 2021; 12(2):160; doi: 10.1038/s41419-021-03452-x
21.
La RosaP, PetrilloS, TurchiR, et al.The Nrf2 induction prevents ferroptosis in Friedreich’s Ataxia. Redox Biol, 2021; 38:101791; doi: 10.1016/j.redox.2020.101791
22.
LakeBB, ChenS, HoshiM, et al.A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys. Nat Commun, 2019; 10(1):2832; doi: 10.1038/s41467-019-10861-2
23.
LangH, DaiC. Effects of bone marrow mesenchymal stem cells on plasminogen activator inhibitor-1 and renal fibrosis in rats with diabetic nephropathy. Arch Med Res, 2016; 47(2):71–77; doi: 10.1016/j.arcmed.2016.03.002
24.
LiJ, CaoF, YinHL, et al.Ferroptosis: Past, present and future. Cell Death Dis, 2020; 11(2):88; doi: 10.1038/s41419-020-2298-2
25.
LiB, CuiW, TanY, et al.Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. J Cell Mol Med, 2014; 18(5):895–906; doi: 10.1111/jcmm.12239
26.
LiX, GaoL, LiX, et al.Autophagy, pyroptosis and ferroptosis are rising stars in the pathogenesis of diabetic nephropathy. Diabetes Metab Syndr Obes, 2024; 17:1289–1299; doi: 10.2147/dmso.S450695
27.
LiJ, JiaYC, DingYX, et al.The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci, 2023; 19(9):2756–2771; doi: 10.7150/ijbs.83348
28.
LiangX, WangPEI, ChenB, et al.Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease. Kidney Int, 2020; 97(1):175–192; doi: 10.1016/j.kint.2019.08.036
29.
LiuL, ChenY, LiX, et al.Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy. Biomed Pharmacother, 2024; 175:116672; doi: 10.1016/j.biopha.2024.116672
30.
MatsumotoM, SasakiN, TsujinoT, et al.Iron restriction prevents diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rat. Ren Fail, 2013; 35(8):1156–1162; doi: 10.3109/0886022x.2013.819729
31.
MuK, YangY, AnX, et al.Proteomic analysis of urinary exosomes reveals ferroptosis-associated proteins are involved in diabetic nephropathy. Genes Dis, 2024; 11(5):101138; doi: 10.1016/j.gendis.2023.101138
32.
NaamanSC, BakrisGL. Diabetic nephropathy: Update on pillars of therapy slowing progression. Diabetes Care, 2023; 46(9):1574–1586; doi: 10.2337/dci23-0030
ShenS, JiC, WeiK. Cellular senescence and regulated cell death of tubular epithelial cells in diabetic kidney disease. Front Endocrinol (Lausanne), 2022; 13:924299; doi: 10.3389/fendo.2022.924299
37.
SongJ, LiuJ, CuiC, et al.Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK/ULK1-mediated autophagy. J Cachexia Sarcopenia Muscle, 2023; 14(2):915–929; doi: 10.1002/jcsm.13177
38.
TangH, YangM, LiuY, et al.The CXCL1-CXCR2 axis mediates tubular injury in diabetic nephropathy through the regulation of the inflammatory response. Front Physiol, 2021; 12:782677; doi: 10.3389/fphys.2021.782677
39.
TervaertTW, MooyaartAL, AmannK, et al.Renal Pathology Society. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol, 2010; 21(4):556–563; doi: 10.1681/asn.2010010010
40.
TortiFM, TortiSV. Regulation of ferritin genes and protein. Blood, 2002; 99(10):3505–3516; doi: 10.1182/blood.v99.10.3505
41.
VallonV, ThomsonSC. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol, 2020; 16(6):317–336; doi: 10.1038/s41581-020-0256-y
42.
Vomhof-DekreyEE, PickloMJ.Sr., The Nrf2-antioxidant response element pathway: A target for regulating energy metabolism. J Nutr Biochem, 2012; 23(10):1201–1206; doi: 10.1016/j.jnutbio.2012.03.005
43.
WangT, HuL, LiR, et al.Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways. J Virol, 2024; 98(4):e0015924; doi: 10.1128/jvi.00159-24
44.
WangL, LiuY, DuT, et al.ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ, 2020; 27(2):662–675; doi: 10.1038/s41418-019-0380-z
45.
WangY, LiuJ, WangH, et al.Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway. Stem Cells, 2023; 41(4):368–383; doi: 10.1093/stmcls/sxad010
46.
WangY, LiuJ, ZhangQ, et al.Human umbilical cord mesenchymal stem cells attenuate podocyte injury under high glucose via TLR2 and TLR4 signaling. Diabetes Res Clin Pract, 2021; 173:108702; doi: 10.1016/j.diabres.2021.108702
47.
WangS, NieP, LuX, et al.Nrf2 participates in the anti-apoptotic role of zinc in Type 2 diabetic nephropathy through Wnt/β-catenin signaling pathway. J Nutr Biochem, 2020; 84:108451; doi: 10.1016/j.jnutbio.2020.108451
48.
WilsonPC, WuH, KiritaY, et al.The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A, 2019; 116(39):19619–19625; doi: 10.1073/pnas.1908706116
49.
WuQ, HuangF. Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy. Ann Med, 2024; 56(1):2346543; doi: 10.1080/07853890.2024.2346543
50.
WuJ, LvR, QiuL, et al.JNK regulates the Nrf2/NQO1-ARE pathway against Microcystins-Induced oxidative stress in freshwater mussel Cristaria plicata. Gene, 2023; 883:147653; doi: 10.1016/j.gene.2023.147653
51.
XieY, HouW, SongX, et al.Ferroptosis: Process and function. Cell Death Differ, 2016; 23(3):369–379; doi: 10.1038/cdd.2015.158
52.
YamamotoM, KenslerTW, MotohashiH. The KEAP1-NRF2 System: A thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev, 2018; 98(3):1169–1203; doi: 10.1152/physrev.00023.2017
53.
YangXD, YangYY. Ferroptosis as a novel therapeutic target for diabetes and its complications. Front Endocrinol (Lausanne), 2022; 13:853822; doi: 10.3389/fendo.2022.853822
54.
YaoL, LiangX, QiaoY, et al.Mitochondrial dysfunction in diabetic tubulopathy. Metabolism, 2022; 131:155195; doi: 10.1016/j.metabol.2022.155195
55.
YinS, LiuW, JiC, et al.hucMSC-sEVs-Derived 14-3-3ζ serves as a bridge between YAP and autophagy in diabetic kidney disease. Oxid Med Cell Longev, 2022; 2022:3281896; doi: 10.1155/2022/3281896
56.
YinN, WuC, QiuJ, et al.Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8(+)CD28(-) T cells. Stem Cell Res Ther, 2020; 11(1):49; doi: 10.1186/s13287-019-1537-x
57.
ZhangH, LiuX, ZhouS, et al.SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy. J Mol Endocrinol, 2018; 60(2):145–157; doi: 10.1530/jme-17-0260
58.
ZhangYH, ZhangYQ, GuoCC, et al.Prostaglandin E1 attenuates high glucose-induced apoptosis in proximal renal tubular cells by inhibiting the JNK/Bim pathway. Acta Pharmacol Sin, 2020; 41(4):561–571; doi: 10.1038/s41401-019-0314-9
59.
ZhaoL, ZhangJ, LeiS, et al.Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end-stage renal disease. J Diabetes, 2021; 13(7):572–584; doi: 10.1111/1753-0407.13150
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
